Healthcare major Sun Pharmaceutical Industries shares plunged more than 6 percent intraday Wednesday on US Food and Drug Administration (USFDA) concerns. According to IIFL, the US health regulator has issued 14-page 483 observations letter after inspection of Sun Pharma's Halol unit in Gujarat.
first published: Dec 7, 2016 10:56 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

